The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Arrowhead Pharmaceuticals Inc
LSE:0HI3
|
US |
|
Carnegie Development Inc
OTC:CDJM
|
US |
|
Air Canada
TSX:AC
|
CA |
|
R
|
Ramsay Health Care Ltd
F:RMY
|
AU |
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
CN |
|
F
|
Flow Capital Corp
CNSX:FW
|
CA |
|
W
|
West Fraser Timber Co Ltd
XHAN:WFC
|
CA |
|
Kabushiki Kaisha Kikuchi Seisakusho
TSE:3444
|
JP |
|
S
|
Shopify Inc
TSX:SHOP
|
CA |
|
Peach Property Group AG
F:P6Z
|
CH |
|
H
|
Halliburton Co
XETRA:HAL
|
US |
|
Krystal Biotech Inc
NASDAQ:KRYS
|
US |
|
Magazine Luiza SA
BOVESPA:MGLU3
|
BR |
|
Volkswagen AG
F:VOW3
|
DE |
|
P
|
Pyramid Technoplast Ltd
NSE:PYRAMID
|
IN |
|
Vale SA
BMV:VALEN
|
BR |
|
Colefax Group PLC
LSE:CFX
|
UK |
|
Medibank Private Ltd
ASX:MPL
|
AU |
|
Z
|
Zeda Ltd
JSE:ZZD
|
ZA |
|
S
|
Starbucks Corp
HKEX:4337
|
US |
|
U
|
United Parcel Service Inc
DUS:UPAB
|
US |
|
H
|
Hon Hai Precision Industry Co Ltd
SWB:HHP2
|
TW |
|
D
|
Daikin Industries Ltd
OTC:DKILY
|
JP |
|
E
|
Equifax Inc
XMUN:EFX
|
US |
Arrowhead Pharmaceuticals Inc (0HI3)’s 12-month stock price forecast through November 2027 has a consensus target of $107.18, implying 84% upside. The forecast is based on price targets from 16 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
0HI3 is 107.18 USD with a low forecast of 73.74 USD and a high forecast of 130.53 USD.
Over the last 13 years, the compound annual growth rate for Revenue has been 100%. The projected CAGR for the next 8 years is 25%.
The compound annual growth rate for Operating Income over the next 8 years is 50%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more